| Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases AB Kunnumakkara, D Bordoloi, G Padmavathi, J Monisha, NK Roy, ... British journal of pharmacology 174 (11), 1325-1348, 2017 | 1139 | 2017 |
| An Update on Pharmacological Potential of Boswellic Acids against Chronic Diseases NK Roy, D Parama, K Banik, D Bordoloi, AK Devi, KK Thakur, ... International Journal of Molecular Sciences 17, 2019 | 221 | 2019 |
| Magnolol: A neolignan from the magnolia family for the prevention and treatment of cancer AM Ranaware, K Banik, V Deshpande, G Padmavathi, NK Roy, G Sethi, ... International journal of molecular sciences 19 (8), 2362, 2018 | 154 | 2018 |
| Butein in health and disease: A comprehensive review G Padmavathi, NK Roy, D Bordoloi, F Arfuso, S Mishra, G Sethi, ... Phytomedicine 25, 118-127, 2017 | 140 | 2017 |
| The potential role of boswellic acids in cancer prevention and treatment NK Roy, A Deka, D Bordoloi, S Mishra, AP Kumar, G Sethi, ... Cancer letters 377 (1), 74-86, 2016 | 135 | 2016 |
| Multi-targeted agents in cancer cell chemosensitization: What we learnt from curcumin thus far D Bordoloi, N K Roy, J Monisha, G Padmavathi, A B Kunnumakkara Recent patents on anti-cancer drug discovery 11 (1), 67-97, 2016 | 119 | 2016 |
| Googling the Guggul (Commiphora and Boswellia) for prevention of chronic diseases AB Kunnumakkara, K Banik, D Bordoloi, C Harsha, BL Sailo, ... Frontiers in pharmacology 9, 686, 2018 | 118 | 2018 |
| Cancer drug development: The missing links AB Kunnumakkara, D Bordoloi, BL Sailo, NK Roy, KK Thakur, K Banik, ... Experimental Biology and Medicine 244 (8), 663-689, 2019 | 108 | 2019 |
| Potential of butein, a tetrahydroxychalcone to obliterate cancer G Padmavathi, SR Rathnakaram, J Monisha, D Bordoloi, NK Roy, ... Phytomedicine 22 (13), 1163-1171, 2015 | 89 | 2015 |
| NGAL is downregulated in oral squamous cell carcinoma and leads to increased survival, proliferation, migration and chemoresistance J Monisha, NK Roy, G Padmavathi, K Banik, D Bordoloi, AD Khwairakpam, ... Cancers 10 (7), 228, 2018 | 82 | 2018 |
| Acorus calamus: a bio-reserve of medicinal values AD Khwairakpam, YD Damayenti, A Deka, J Monisha, NK Roy, ... Journal of basic and clinical physiology and pharmacology 29 (2), 107-122, 2018 | 76 | 2018 |
| Specific targeting of Akt kinase isoforms: Taking the precise path for prevention and treatment of cancer N Kishor Roy, D Bordoloi, J Monisha, G Padmavathi, J Kotoky, R Golla, ... Current drug targets 18 (4), 421-435, 2017 | 61 | 2017 |
| NF-κB blockers gifted by mother nature: Prospectives in cancer cell chemosensitization J Monisha, G Padmavathi, NK Roy, A Deka, D Bordoloi, A Anip, ... Current pharmaceutical design 22 (27), 4173-4200, 2016 | 60 | 2016 |
| A BAFF ligand-based CAR-T cell targeting three receptors and multiple B cell cancers DP Wong, NK Roy, K Zhang, A Anukanth, A Asthana, NJ Shirkey-Son, ... Nature communications 13 (1), 217, 2022 | 56 | 2022 |
| An investigation on the therapeutic potential of butein, a tretrahydroxychalcone against human oral squamous cell carcinoma D Bordoloi, J Monisha, M Roy, G Padmavathi, K Banik, C Harsha, H Wang, ... Asian Pacific journal of cancer prevention: APJCP 20 (11), 3437, 2019 | 54 | 2019 |
| Nuclear factor kappa B: a potential target to persecute head and neck cancer J Monisha, N Kishor Roy, D Bordoloi, A Kumar, R Golla, J Kotoky, ... Current drug targets 18 (2), 232-253, 2017 | 54 | 2017 |
| Isoform-Specific Role of Akt in Oral Squamous Cell Carcinoma NK Roy, J Monisha, G Padmavathi, H Lalhruaitluanga, NS Kumar, ... Biomolecules 9 (7), 253, 2019 | 48 | 2019 |
| TIPE2 induced the proliferation, survival, and migration of lung cancer cells through modulation of Akt/mTOR/NF-κB signaling cascade D Bordoloi, K Banik, G Padmavathi, R Vikkurthi, C Harsha, NK Roy, ... Biomolecules 9 (12), 836, 2019 | 47 | 2019 |
| Orai-1 and Orai-2 regulate oral cancer cell migration and colonisation by suppressing Akt/mTOR/NF-κB signalling AK Singh, NK Roy, D Bordoloi, G Padmavathi, K Banik, AD Khwairakpam, ... Life Sciences 261, 118372, 2020 | 41 | 2020 |
| In silico molecular modelling of selected natural ligands and their binding features with estrogen receptor alpha VL Maruthanila, R Elancheran, NK Roy, A Bhattacharya, ... Current computer-aided drug design 15 (1), 89-96, 2019 | 40 | 2019 |
